Junqing Hou

568 total citations
25 papers, 428 citations indexed

About

Junqing Hou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junqing Hou has authored 25 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junqing Hou's work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Junqing Hou is often cited by papers focused on Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Junqing Hou collaborates with scholars based in China. Junqing Hou's co-authors include Xinyi Du, Junkai Chang, Weibo Xu, Zhenhua Zhao, Wenchao Xu, Xiaolei Zhao, Hui Liu, Xiaobo Nie, Yifan Hou and Gang Xia and has published in prestigious journals such as Biochemical Pharmacology, BMC Public Health and Cell Death and Disease.

In The Last Decade

Junqing Hou

20 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junqing Hou China 11 292 280 85 58 35 25 428
Gallina Kazobinka China 11 311 1.1× 148 0.5× 77 0.9× 87 1.5× 47 1.3× 20 405
Huohui Ou China 10 280 1.0× 212 0.8× 97 1.1× 81 1.4× 32 0.9× 16 405
Fuchao Ma China 13 319 1.1× 223 0.8× 50 0.6× 60 1.0× 32 0.9× 25 407
Ana Lameirinhas Portugal 12 269 0.9× 188 0.7× 54 0.6× 72 1.2× 28 0.8× 18 386
Zhiqi Yao China 4 260 0.9× 276 1.0× 38 0.4× 71 1.2× 32 0.9× 4 383
Haizhou Guo China 12 259 0.9× 212 0.8× 55 0.6× 52 0.9× 70 2.0× 21 379
Xuetao Lei China 7 238 0.8× 163 0.6× 156 1.8× 48 0.8× 35 1.0× 10 342
Bensong Duan China 13 265 0.9× 209 0.7× 48 0.6× 47 0.8× 52 1.5× 27 363
Jinyu Xiang China 11 266 0.9× 126 0.5× 57 0.7× 94 1.6× 36 1.0× 20 357
Yuanhui Lai China 10 274 0.9× 192 0.7× 60 0.7× 68 1.2× 25 0.7× 15 352

Countries citing papers authored by Junqing Hou

Since Specialization
Citations

This map shows the geographic impact of Junqing Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Hou more than expected).

Fields of papers citing papers by Junqing Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqing Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Hou. The network helps show where Junqing Hou may publish in the future.

Co-authorship network of co-authors of Junqing Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Junqing Hou. A scholar is included among the top collaborators of Junqing Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqing Hou. Junqing Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Chang, Bo, Yifan Hou, Wenbin Li, et al.. (2025). Solitary testicular metastasis post-prostatectomy for prostatic ductal adenocarcinoma: case report and literature review. Frontiers in Oncology. 15. 1464446–1464446. 1 indexed citations
4.
Pan, Li, Yifan Hou, Yuanyuan Sun, et al.. (2025). Mechanistic insights into the Ganfule capsule in alleviating alcoholic liver disease. Bioorganic Chemistry. 166. 109144–109144.
5.
Han, Jing, Jianhua Zhang, Yifan Hou, et al.. (2025). Regulatory effect of Wnt signaling on mitochondria in cancer: from mechanism to therapy. APOPTOSIS. 30(5-6). 1235–1252.
6.
Xu, Hongtao, Yifan Hou, Zhenhua Zhao, et al.. (2025). CBP/p300, a promising therapeutic target for prostate cancer. Journal of Translational Medicine. 23(1). 1045–1045.
7.
Wang, Zheng, et al.. (2024). Cross-talk between WNT Signaling and Ferroptosis in Cancer. Molecular Cancer Research. 23(3). 175–189.
8.
Wang, Huijuan, Meihua Qu, Xin Hou, et al.. (2024). Redox homeostasis of one-carbon metabolism-dependent reprogramming is critical for RCC progression under exogenous serine/glycine-deprived conditions. BMC Cancer. 24(1). 1515–1515. 3 indexed citations
9.
Zhang, Haojie, et al.. (2024). Emerging Diabetes Therapies: Regenerating Pancreatic β Cells. Tissue Engineering Part B Reviews. 30(6). 644–656. 3 indexed citations
10.
Hou, Yifan, Li Pan, Yi Zhang, et al.. (2024). Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189186–189186. 8 indexed citations
11.
Wu, Dapeng, Yifan Hou, Yi Zhang, et al.. (2024). Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights. Biochemical Pharmacology. 223. 116154–116154. 23 indexed citations
12.
Liu, Zhangnan, Junqing Hou, Hailong Zhang, et al.. (2023). Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming. Cell Death and Disease. 14(2). 144–144. 23 indexed citations
13.
Zhao, Xiaolei, Zhenhua Zhao, Wenchao Xu, et al.. (2020). <p>Circ-SAR1A Promotes Renal Cell Carcinoma Progression Through miR-382/YBX1 Axis</p>. Cancer Management and Research. Volume 12. 7353–7361. 17 indexed citations
14.
Li, Bin, Lu Zheng, Shengzheng Wang, et al.. (2020). Pretreatment elevated prognostic nutritional index predicts a favorable prognosis in patients with prostate cancer. BMC Cancer. 20(1). 361–361. 33 indexed citations
16.
Liu, Hui, Xiaolong Song, Junqing Hou, Zhenhua Zhao, & Junkai Chang. (2018). Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells. DNA and Cell Biology. 37(3). 210–219. 12 indexed citations
17.
Chang, Junkai, Weibo Xu, Xinyi Du, & Junqing Hou. (2018). MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS. OncoTargets and Therapy. Volume 11. 3461–3473. 61 indexed citations
18.
Hou, Junqing, Zhenhua Zhao, Tie‐Qiang Li, et al.. (2017). Expression of speckle-type poxvirus and zinc finger protein in prostate cancer. Zhonghua shiyan waike zazhi. 34(3). 509–511. 1 indexed citations
19.
Li, Yang, Hui Liu, Junkai Chang, Zhenhua Zhao, & Junqing Hou. (2017). Effects of exogenous hydrogen sulfide on the proliferation and invasion of human Bladder cancer cells. Journal of Cancer Research and Therapeutics. 13(5). 829–829. 13 indexed citations
20.
Xu, Weibo, Junkai Chang, Xinyi Du, & Junqing Hou. (2017). Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer. Biomedicine & Pharmacotherapy. 95. 1112–1118. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026